EXACT Therapeutics AS (OSL:EXTX)
0.6050
-0.1150 (-15.97%)
At close: Sep 11, 2026
EXACT Therapeutics AS Market Cap
EXACT Therapeutics AS has a market cap or net worth of 38.27 million as of September 11, 2026. Its market cap has decreased by -72.99% in one year.
Market Cap
38.27M
Enterprise Value
-10.77M
Revenue
78.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.61
ChartMarket Cap Chart
Since July 14, 2020, EXACT Therapeutics AS's market cap has decreased from 953.69M to 38.27M, a decrease of -95.99%. That is a compound annual growth rate of -40.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 38.27M | -56.16% |
| Dec 30, 2025 | 87.30M | -63.30% |
| Dec 30, 2024 | 237.87M | -38.21% |
| Dec 29, 2023 | 384.97M | 6.95% |
| Dec 30, 2022 | 359.97M | -31.02% |
| Dec 30, 2021 | 521.86M | -40.97% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 3.50B |
| Thor Medical ASA | 1.99B |
| Nykode Therapeutics AS | 1.29B |
| ArcticZymes Technologies ASA | 1.08B |
| Lytix Biopharma ASA | 645.96M |
| Zelluna ASA | 602.98M |
| Oncoinvent ASA | 602.35M |
| SoftOx Solutions AS | 312.22M |